Arteritis Clinical Trials

1 recruiting

Frequently Asked Questions

Common questions about Arteritis clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 48 trials

Recruiting
Phase 2

Tocilizumab Discontinuation Versus Dose Reduction for Patients With Well-Controlled Giant Cell Arteritis

Giant Cell Arteritis (GCA)
National Institute of Allergy and Infectious Diseases (NIAID)78 enrolled7 locationsNCT07108387
Recruiting

Studies of the Natural History, Pathogenesis, and Outcome of Idiopathic Systemic Vasculitis

Giant Cell ArteritisTakayasu's ArteritisRelapsing Polychondritis+1 more
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)4,000 enrolled1 locationNCT02257866
Recruiting

Association of Ultrasonographic Temporal Artery Lesions and Relapse in Patients With Giant Cell Arteritis

Giant Cell Arteritis
University Hospital, Brest100 enrolled2 locationsNCT06894602
Recruiting
Not Applicable

Biologic Treatment Withdrawal in Takayasu Arteritis Patients in Sustained Remission

Takayasu Arteritis
Marmara University40 enrolled1 locationNCT07491913
Recruiting
Phase 4

Effect of Supplemental Hydrocortisone During Stress in Prednisolone-induced Adrenal Insufficiency

Adrenal InsufficiencyGiant Cell ArteritisPolymyalgia Rheumatica
Marianne Christina Klose250 enrolled3 locationsNCT05435781
Recruiting

Rheumatology Patient Registry and Biorepository

Rheumatoid ArthritisLyme DiseaseSarcoidosis+17 more
Yale University5,000 enrolled1 locationNCT04402086
Recruiting

One-Time DNA Study for Vasculitis

Microscopic PolyangiitisGiant Cell ArteritisTakayasu's Arteritis+3 more
University of Pennsylvania1,000 enrolled14 locationsNCT01241305
Recruiting

Vasculitis Pregnancy Registry

Behcet's DiseaseVasculitisCNS Vasculitis+12 more
University of Pennsylvania100 enrolled1 locationNCT02593565
Recruiting

Clinical Transcriptomics in Systemic Vasculitis (CUTIS)

VasculitisIgA VasculitisMicroscopic Polyangiitis (MPA)+7 more
Peter Merkel50 enrolled10 locationsNCT03004326
Recruiting

VCRC Tissue Repository

Microscopic PolyangiitisGiant Cell ArteritisTakayasu Arteritis+8 more
University of Pennsylvania1,000 enrolled8 locationsNCT02967068
Recruiting
Phase 3

Abatacept for the Treatment of Giant Cell Arteritis

Giant Cell Arteritis
University of Pennsylvania78 enrolled9 locationsNCT04474847
Recruiting
Phase 2

A Randomized Multicenter Study for Isolated Skin Vasculitis

IgA VasculitisHenoch-Schönlein PurpuraPrimary Cutaneous Vasculitis+1 more
University of Pennsylvania90 enrolled16 locationsNCT02939573
Recruiting
Phase 2

Dapagliflozin and Endothelin Receptor Antagonism in Large Vessel Vasculitis (DERAIL-LVV)

Giant Cell Arteritis (GCA)Takayasu ArteritisLarge Vessel Vasculitis
University of Edinburgh60 enrolled1 locationNCT06887062
Recruiting

Investigating Management, Perspectives and Attitudes Towards Care in Takayasu Arteritis

Takayasu ArteritisTakayasu Arteritis (TAK)
University of Edinburgh50 enrolled1 locationNCT07351422
Recruiting

Impact of the Spatial Resolution of Several Contrast-enhanced 3D T1-WI Sequences When Diagnosing Giant Cell Arteritis (GCA)

Giant Cell Arteritis
Fondation Ophtalmologique Adolphe de Rothschild133 enrolled1 locationNCT05854927
Recruiting

Giant Cell Arteritis - Ways to Precision Medicine

Giant Cell ArteritisPolymyalgia Rheumatic (PMR)
Wuerzburg University Hospital400 enrolled1 locationNCT07084480
Recruiting
Phase 4

Hydrocortisone and Placebo in Patients With Symptoms of Adrenal Insufficiency After Cessation of Glucocorticoid Treatment

Adrenal InsufficiencyGiant Cell Arteritis (GCA)Polymyalgia Rheumatica (PMR)
Marianne Andersen100 enrolled3 locationsNCT05193396
Recruiting

Physical and Psychosocial Parameters in Takayasu Arteritis and Behçet's Disease: A Comparative Study With Healthy Controls

Takayasu ArteritisBehçet's Disease
ÖZLEM NUR TOK YAMAN30 enrolled1 locationNCT07276087
Recruiting

Clinical Features and Prognosis of Takayasu's Arteritis With Pulmonary Arteries Involvement

Takayasu Arteritis With Pulmonary Artery InvolvementPulmonary Arterial Hypertension Associated With Connective Tissue Disease
China-Japan Friendship Hospital150 enrolled1 locationNCT07184814
Recruiting

Vascular MRI Evaluation in Giant Cell Arteritis (VEGA)

Giant Cell Arteritis
University of Pennsylvania400 enrolled4 locationsNCT05865054